Edgestream Partners »

Intellia Therapeutics shares owned by Edgestream Partners

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $658k 22k 30.49

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Apple (AAPL)
McKesson Corporation (MCK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
AmerisourceBergen (COR)
Phillips Edison & Co Common Stock (PECO)
Republic Services (RSG)
Targa Res Corp (TRGP)
Bellring Brands Common Stock (BRBR)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Edgestream Partners

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Wellington Management Company
FMR
Geode Capital Management
Federated Investors
Casdin Capital
Alliancebernstein
T. Rowe Price Associates
Rokos Capital Management
Contrarius Investment Management

View all funds holding Intellia Therapeutics